Chicken little forecast

Still Chugging Along

Volcanoes are erupting in The Philippines, but on-fire Australia received some welcome rain. The Iran war cries have been called off and The Donald’s military powers are about to be hamstrung by the Senate. Meanwhile, his impeachment trial is starting, and we’re all on Twitter for a front-row seat.


What Could Go Right? Phasing out animal testing

It won’t disappear overnight, but with new regulation, a shift has begun.

Emma Varvaloucas

Emma Varvaloucas

This is our weekly newsletter, What Could Go Right? Sign up here to receive it in your inbox every Thursday at 6am ET. You can read past issues here.

Goodbye animal testing, hello third RSV vaccine

This week is one for health news. Three things we see moving in the right direction:

One, the United States Food and Drug Administration (FDA) has lifted the requirement for new medicines to be tested on animals before moving to human trials, a rule that has been in place since 1938. This won’t mean that testing on animals will stop overnight, but it does signal a willingness from the FDA to consider a slow fade-out of it. Concurrently, the FDA is spending $5 million this year to “develop methods to replace, reduce, and refine animal testing.” These “nonanimal methods” include options like tissue-lined chips that are designed to respond like human organs. 

This move from the FDA is a thumbs up for those concerned with animal welfare as well as those concerned with getting life-saving drugs more quickly and cheaply to market. Indeed, the idea came from Senator Rand Paul (R–KY) and Senator Cory Booker (D–NJ) on the back of blooming public sentiment. More and more Americans view medical testing on animals to be “morally wrong”—43 percent in 2022, up from 26 percent in 2001. Science has the whole scoop, including how the FDA will continue to ensure the safety of new products, here.

Two, it’s not just Gen Z that has done a good job quitting smoking. A new report documents a 33 percent decline in cancer mortality in the US since 1991, the peak of death rates. While that number accounts for all types of cancers, it is largely a reversal of the tobacco epidemic that started in the 1930s and led to a “rapid increase in lung cancer deaths among men.” 

Trends in the US cancer mortality rate by sex and cancer type from 1930 to 2020. Note the dramatic reduction in lung cancer death post-1990. | Credit: ACS Journals

Fewer people smoking, the report says, as well as “improvements in early detection and treatment for some cancers have resulted in a continuous decline in the cancer death rate.” In human terms, that 33 percent translates into four million deaths avoided. The report itself is dense but CNN has a comprehensive overview of it here.

Three, the entry of a third effective vaccine for RSV. On Tuesday, pharmaceutical company Moderna announced that their vaccine, which uses mRNA technology, was 84 percent effective at preventing less severe disease in adults aged 60 and above. Two other RSV vaccines, from Pfizer and Glaxo Smith Kline, neither of which use mRNA, are awaiting FDA approval in the summertime. 

By next winter’s Covid-flu-RSV triple threat, then, we should be in better shape than ever before to protect older adults. As for kids, Pfizer is working on a maternal vaccine that would transfer protection to newborns. (P.S. Speaking of the triple threat, an improvement currently sliding under the radar is that we haven’t yet experienced a Covid surge this year, as we already had by now the last two winters.)

Before we go

This 13-minute YouTube video from PBS is an excellent and fair overview of the progress the world has made and not made on climate change.

If cannabis is legalized in a state, does it make sense for cannabis convictions to remain on people’s records? No, it does not, and Connecticut agrees. Earlier in January, lawmakers there expunged the records of more than 43,000 low-level cannabis convictions. In addition to being fair, this is a helpful step when it comes to reducing racial disparities in the US’ criminal justice system.

We spotted this piece of news in Jessica Yellin’s News Not Noise newsletter: After only 64 percent of Apple’s shareholders approved his compensation in 2021, “head of Apple Tim Cook took a voluntary 40 percent pay cut this year—cutting his target compensation from over $84 million in 2022 to $49 million for 2023.” As Yellin points out, where Apple goes, other companies follow. Could we see the bloated CEO salary trend finally start to deflate?

Below in the links section, CRISPR versus cancer, MDMA for PTSD, diversity in Congress, and more.

Homicides in New York City fell by around 12 percent last year compared to 2021, and they are down significantly from a peak in 1990.

Progress, Please

(Found good news? Tweet at us @progressntwrk or email.)

Other good stuff in the news 🛰️

Energy & Environment:

Science & Tech:

Politics & Policy:

Public Health:

Society & Culture:

TPN Member originals 🧠

(Who are our Members? Get to know them.)

Department of Ideas 💡
(A staff recommendation guaranteed to give your brain some food for thought.)

Bending the moral arc | Skeptic
Honoring Dr. Martin Luther King Jr. nearly 60 years after his “How Long” speech in Montgomery, Alabama on March 25, 1965

Why we picked it: Is cumulative human progress a myth? Are things like moral and social progress actually achievable, or do the concepts depend too much on our individual, and disparate, values? Is the arc of progress really an endless circle of tradeoffs? I have at least as many doubts as I do hopes, but this piece fed the latter. —Brian Leli

New Member Alert

Historian Rutger Bregman has published five books on history, philosophy, and economics. His books Humankind (2020) and Utopia for Realists (2017) were both New York Times Bestsellers and have been translated in more than 40 languages. Bregman has twice been nominated for the prestigious European Press Prize for his work at The Correspondent, an online platform for unbreaking news, committed to collaborative, constructive, ad-free journalism. He lives in Holland.

Watch Bregman’s TED Talk on poverty and guaranteed basic income.

Until Next Time

All in favor of letting the bus drivers be our societal guides say aye.👇

Leave a Comment

Your email address will not be published. Required fields are marked *

Post a Comment
Emma Varvaloucas

Emma Varvaloucas is the Executive Director of The Progress Network. An editor and writer specializing in nonprofit media, she was formerly Executive Editor of Tricycle: The Buddhist Review and is the editor of two books from Wisdom Publications.